Glyn Stacey, Chief Executive at SSCBio leads a discussion on the current landscape of ‘Cell Therapy Analytics'.

Amir Reza Goudarzi, former Engineering Head of UCB in Brussels, leads a discussion on ‘Upstream Bioprocessing.'

Key opinion leaders from Novartis, Achilles Therapeutics, and AbbVie divulge their views on what's next for upstream bioprocessing.

This Commentary article investigates the potential applications of digital twins in refining the developmental timeline for drug substance development. Capturing and conserving the understanding from ongoing processes allows researchers to learn more about the intricacies of the developmental process more rapidly.

Will 3D model development reach its potential to innovate cell and gene therapeutics? We spoke to Merck, GlaxoSmithKline, East Carolina University Brody School of Medicine, and the Institute of Molecular Biotechnology to find out more.

Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘3D Model Development' brought together an exclusive panel of key opinion leaders to address the market's growth and future directions.

Raymond R. Mattingly explains the applications of 3D cell culturing at Oxford Global's 3D Cell Culture Symposium.